How should healthcare companies manage AI-generated health information that mentions them?

Healthcare AI reputation work carries unusual stakes because the engines’ answers about medical and pharmaceutical topics can affect patient decisions, clinician behavior, and regulatory posture. Incorrect AI claims associated with a healthcare brand – misstated indications, wrong contraindications, fabricated trial results, inaccurate adverse-event characterizations – create real-world harm and real regulatory exposure beyond the reputational layer. The monitoring discipline is correspondingly tighter: daily AIQ™ polling across the eight engines with prompts covering products, conditions, comparisons, and safety topics. The source ecosystem is structured and high-authority: peer-reviewed literature, FDA labeling, NIH resources, major medical reference sites, professional society guidelines. The work is unglamorous but the consequences of neglecting it are substantial.